There is limited information for Black patients about prostate cancer, and the information that is available is often inaccessible and of low quality.26 While current guidelines vary in their recommendations for prostate cancer screening, all recommend shared decision-making between patient and clinician as foundational in determining which patients should ultimately receive PSA testing. Here, KLK3 is linked to prostate carcinoma.